Pan-cancer analysis and breast cancer validation reveal DEAD-box helicase 23 as a crucial prognostic and immuno-biomarker.
APA
Ma H, Aimaiti X, et al. (2026). Pan-cancer analysis and breast cancer validation reveal DEAD-box helicase 23 as a crucial prognostic and immuno-biomarker.. Scientific reports. https://doi.org/10.1038/s41598-026-48258-z
MLA
Ma H, et al.. "Pan-cancer analysis and breast cancer validation reveal DEAD-box helicase 23 as a crucial prognostic and immuno-biomarker.." Scientific reports, 2026.
PMID
41986534
같은 제1저자의 인용 많은 논문 (5)
- An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer.
- Integrated design and application of metal-organic frameworks in ferroptosis-mediated cancer therapy.
- Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.
- Drug screening reveals the mechanism of toyocamycin-induced apoptosis in triple-negative breast cancer organoids.
- Contrast-enhanced ultrasound-guided liver biopsy with flow cytometry analysis for the diagnosis of secondary hemophagocytic syndrome: A case report.